Search Results - "Gea, S"

Refine Results
  1. 1
  2. 2

    Modeling Glutaric Aciduria Type I in human neuroblastoma cells recapitulates neuronal damage that can be rescued by gene replacement by Mateu-Bosch, A., Segur-Bailach, E., García-Villoria, J., Gea-Sorlí, S., Ruiz, I., del Rey, J., Camps, J., Guitart-Mampel, M., Garrabou, G., Tort, F., Ribes, A., Fillat, C.

    Published in Gene therapy (01-01-2024)
    “…Glutaric Aciduria type I (GA1) is a rare neurometabolic disorder caused by mutations in the GDCH gene encoding for glutaryl-CoA dehydrogenase (GCDH) in the…”
    Get full text
    Journal Article
  3. 3

    Bacterial cellulose–poly(vinyl alcohol) nanocomposites prepared by an in-situ process by Gea, S., Bilotti, E., Reynolds, C.T., Soykeabkeaw, N., Peijs, T.

    Published in Materials letters (30-04-2010)
    “…Bio-nanocomposites were prepared by an in-situ growth process through the direct addition of poly(vinyl alcohol) (PVA) into the Acetobacter xylinum inoculated…”
    Get full text
    Journal Article
  4. 4

    Burnout and engagement among resident doctors in the Netherlands: a national study by Prins, Jelle T, Hoekstra-Weebers, Josette E H M, Gazendam-Donofrio, Stacey M, Dillingh, Gea S, Bakker, Arnold B, Huisman, Mark, Jacobs, Bram, Van Der Heijden, Frank M M A

    Published in Medical education (01-03-2010)
    “…Medical Education 2010: 44 : 236–247 Objectives  This study was performed in order to gather insight into the well‐being of Dutch medical residents. Methods …”
    Get full text
    Journal Article
  5. 5

    Total Leishmania antigens with Poly(I:C) induce Th1 protective response by Sanchez, M. V., Eliçabe, R. J., Di Genaro, M. S., Germanó, M. J., Gea, S., García Bustos, M. F., Salomón, M. C., Scodeller, E. A., Cargnelutti, D. E.

    Published in Parasite immunology (01-11-2017)
    “…Summary Our proposal was to develop a vaccine based on total Leishmania antigens (TLA) adjuvanted with polyinosinic‐polycytidylic acid [Poly(I:C)] able to…”
    Get full text
    Journal Article
  6. 6

    In vitro activity of N-benzenesulfonylbenzotriazole on Trypanosoma cruzi epimastigote and trypomastigote forms by Becerra, M.C., Guiñazú, N., Hergert, L.Y., Pellegrini, A., Mazzieri, M.R., Gea, S., Albesa, I.

    Published in Experimental parasitology (01-05-2012)
    “…N-Benzenesulfonylbenzotriazole (BSBZT) could be a prototype for the development of anti-Trypanosoma cruzi drugs. Incubation of epimastigotes and…”
    Get full text
    Journal Article
  7. 7

    The relationship between reciprocity and burnout in Dutch medical residents by Prins, Jelle T, Gazendam-Donofrio, Stacey M, Dillingh, Gea S, Van De Wiel, Harry B M, Van Der Heijden, Frank M M A, Hoekstra-Weebers, Josette E H M

    Published in Medical education (01-07-2008)
    “…Objective  This study examined reciprocity in medical residents’ relationships with supervisors, fellow residents, nurses and patients, and associations…”
    Get full text
    Journal Article
  8. 8

    Nitric oxide synthase 2 (NOS2) expression in histologically normal margins of oral squamous cell carcinoma by Morelatto, Rosana, Itoiz, María-Elina, Guiñazú, Natalia, Piccini, Daniel, Gea, Susana, López-de Blanc, Silvia

    “…The activity of Nitric Oxide Synthase 2 (NOS2) was found in oral squamous cell carcinomas (OSCC) but not in normal mucosa. Molecular changes associated to…”
    Get full text
    Journal Article
  9. 9

    4CPS-148 Clinical evaluation and satisfaction of patients treated with PRGF-Endoret (plasma rich in growth factors) by Gea Navarrete, S, Montero Hernández, M, Belló Crespo, M, Rubio Alonso, L, Román, Á Santiuste, Soler Company, E

    “…Background and importancePRGF-Endoret is an autologous preparation obtained from the patient‘s own blood containing a set of proteins specifically addressing…”
    Get full text
    Journal Article
  10. 10

    5PSQ-051 Immune related adverse events in cancer patients treated with control point inhibitors by Santiuste Roman, A, Bello Crespo, M, Segui Gregori, I, Montero Hernandez, M, Gea Navarrete, S, Soler Company, E

    “…Background and importanceDespite the clinical benefits of therapy with control point inhibitors in several malignancies, this inhibition is closely linked to a…”
    Get full text
    Journal Article
  11. 11

    Carotenoids from persimmon juice processing by Gea-Botella, S., Agulló, L., Martí, N., Martínez-Madrid, M.C., Lizama, V., Martín-Bermudo, F., Berná, G., Saura, D., Valero, M.

    Published in Food research international (01-03-2021)
    “…[Display omitted] •Revalorization of by-products derived from industrialization of persimmon juice was approached.•By-product B resulting from an enzymatic…”
    Get full text
    Journal Article
  12. 12

    Spleen B cells from BALB/c are more prone to activation than spleen B cells from C57BL/6 mice during a secondary immune response to cruzipain by Pellegrini, Andrea, Guiñazú, Natalia, Aoki, Maria Pilar, Calero, Isabel Chico, Carrera-Silva, Eugenio Antonio, Girones, Nuria, Fresno, Manuel, Gea, Susana

    Published in International immunology (01-12-2007)
    “…There is an increasing interest in the study of roles that B cells may play in regulating immune responses both in protection and in pathogenesis. However,…”
    Get full text
    Journal Article
  13. 13

    Anti‐galectin‐1 autoantibodies in human Trypanosoma cruzi infection: differential expression of this β‐galactoside‐binding protein in cardiac Chagas' disease by Giordanengo, L., Gea, S., Barbieri, G., Rabinovich, G. A.

    Published in Clinical and experimental immunology (01-05-2001)
    “…The pathogenesis of Chagas' disease has been subject of active research and still remains to be ascertained. Galectin‐1 (Gal‐1), a member of a conserved family…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Trypanosoma cruzi: Chemotherapeutic effects of clomipramine in mice infected with an isolate obtained from an endemic area by Rivarola, H.W., Bustamante, J.M., Lo Presti, S., Fernández, A.R., Enders, J.E., Gea, S., Fretes, R., Paglini-Oliva, P.

    Published in Experimental parasitology (01-10-2005)
    “…The susceptibility of Trypanosoma cruzi strains to nifurtimox and benznidazole has been investigated and resistant strains have been described. Some tricyclic…”
    Get full text
    Journal Article
  16. 16

    Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice by Lo Presti, M.S, Rivarola, H.W, Bustamante, J.M, Fernández, A.R, Enders, J.E, Fretes, R, Gea, S, Paglini-Oliva, P.A

    “…Trypanosoma cruzi trypanothione reductase is an enzyme that has been identified as a potential target for chemotherapy. Thioridazine inhibits it and prevented…”
    Get full text
    Journal Article
  17. 17

    Antibodies to an epitope from the Cha human autoantigen are markers of Chagas' disease by Gironès, N, Rodríguez, C I, Basso, B, Bellon, J M, Resino, S, Muñoz-Fernández, M A, Gea, S, Moretti, E, Fresno, M

    “…Chagas' disease is a prevalent disease in South America that is thought to have an autoimmune etiology. We previously identified human Cha as a new autoantigen…”
    Get full text
    Journal Article
  18. 18

    Effects of clomipramine on Trypanosoma cruzi infection in mice by Rivarola, H.W., Fernández, A.R., Enders, J.E., Fretes, R., Gea, S., Paglini-Oliva, P.

    “…Trypanosoma cruzi, widely distributed in Latin American countries, provokes Chagas disease, characterized by cardiomyopathy and mega-viscera. The drugs used…”
    Get full text
    Journal Article
  19. 19
  20. 20